封面
市场调查报告书
商品编码
1613191

冠状动脉疾病市场:按类型、最终用户划分 - 全球预测 2025-2030

Coronary Artery Disease Market by Type (Diagnostics, Treatment), End-User (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals & Clinics) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年冠心病市场价值为118.8亿美元,预计到2024年将达到125.3亿美元,复合年增长率为5.68%,到2030年将达到174.9亿美元。

冠状动脉疾病 (CAD) 是一种心血管疾病,斑块堆积会使冠状动脉变窄并减少流向心臟的血流。这种疾病本质上很严重,因为它是全世界死亡的主要原因之一。人口老化的加剧和生活方式的改变增加了风险因素,因此需要对新技术进行深入研究和应用。 CAD 相关的最终用途涵盖医院、诊断中心和专科诊所,并且越来越关注预防性和微创手术。 CAD 市场的关键成长要素包括诊断技术的进步,例如用于预测分析的人工智慧、穿戴式健康监测设备以及远端医疗的广泛采用。主要透过基因分析和新型药物输送系统对个人化医疗的日益关注,正在为相关人员创造重要的商机。为了利用这些机会,公司应该投资创新治疗方法的研发,以解决 CAD 管理中未满足的需求,例如基因治疗、干细胞治疗和生物可吸收支架开发。然而,与先进处理技术相关的高成本和监管挑战等限制可能会阻碍市场扩张。此外,开发中地区对医疗基础设施的依赖也是一个突出的挑战。激烈的市场竞争需要透过技术创新和策略联盟来实现差异化。创新研究领域包括探索基因静默中的微型RNA、增强 CAD 中基因组编辑的 CRISPR 以及透过 3D 列印开发心血管生物材料。市场洞察凸显了新兴经济体作为开拓市场的重要作用,因为医疗保健支出不断增加。在全面市场分析的支持下,持续创新和策略定位对于希望在动态 CAD 市场中获得吸引力并扩大影响力的公司至关重要。

主要市场统计
基准年[2023] 118.8亿美元
预测年份 [2024] 125.3亿美元
预测年份 [2030] 174.9亿美元
复合年增长率(%) 5.68%

市场动态:快速发展的冠状动脉疾病市场的关键市场洞察

供应和需求的动态相互作用正在改变冠状动脉疾病市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,并了解消费行为及其对製造成本的影响,并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 随着人口老化,冠状动脉疾病增加
    • 医疗基础设施投资增加导致医疗基础建设
  • 市场限制因素
    • 深度处理设备高成本,先进技术商业化有限
  • 市场机会
    • CAD 管理产品的进步与改进
    • 持续扩大微创手术和手术中心
  • 市场挑战
    • 因安全问题而导致产品召回的问题

波特五力:驾驭冠状动脉疾病市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解冠状动脉疾病市场的外部影响

外部宏观环境因素在塑造冠状动脉疾病市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。

市场占有率分析 了解冠状动脉疾病市场的竞争格局

冠状动脉疾病市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的见解,以应对日益激烈的竞争。

FPNV 定位矩阵冠状动脉疾病市场供应商的绩效评估

FPNV 定位矩阵是评估冠状动脉疾病市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了冠状动脉疾病市场的成功之路

冠状动脉疾病市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化导致冠心病发病率增加
      • 由于医疗基础设施投资增加而扩大医疗基础设施
    • 抑制因素
      • 深度处理设备高成本,先进技术商业化受到限制
    • 机会
      • CAD 管理产品的进步与改进
      • 持续扩大微创手术和手术中心
    • 任务
      • 因安全问题而涉及产品召回的问题
  • 市场区隔分析
    • 类型:对手术的需求不断增加,以有效管理 CAD 并提高生活质量
    • 最终使用者:高度偏好提供全面 CAD 照护的医院和诊所
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 冠状动脉疾病市场:依类型

  • 诊断
    • 心导管检查及血管造影术
    • 心臟超音波图
    • 心电图
    • 运动压力测试
    • 心臟电脑断层扫描
    • 核子压力测试
  • 治疗
    • 药品
      • 血管张力素转化酵素抑制剂和血管收缩素II受体阻断剂硝酸甘油
      • 阿斯匹灵
      • β受体阻断剂
      • 钙离子通道阻断剂
      • 胆固醇药
      • 雷诺嗪
    • 外科手术
      • 冠状动脉血管成形术和置入术
      • 冠状动脉绕道手术手术

第七章 冠状动脉疾病市场:依最终使用者分类

  • 门诊手术中心
  • 诊断中心
  • 医院/诊所

第八章美洲冠状动脉疾病市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区冠心病市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的冠心病市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • Abbott 推出改良的 Xience Sierra 支架系统以改善心臟治疗
    • 创新Start-Ups利用人工智慧技术彻底改变冠状动脉疾病检测
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Edwards Lifesciences
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Genesee Biomedical Inc.
  • Getinge AB
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Merck KGaA
  • MicroPort Scientific Corporation
  • Siemens Healthineer AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-5D693B46C822

The Coronary Artery Disease Market was valued at USD 11.88 billion in 2023, expected to reach USD 12.53 billion in 2024, and is projected to grow at a CAGR of 5.68%, to USD 17.49 billion by 2030.

Coronary Artery Disease (CAD) falls under cardiovascular diseases involving the narrowing of coronary arteries due to plaque buildup, leading to reduced blood flow to the heart. This condition is inherently critical due to its prevalence as a leading cause of mortality worldwide. The necessity for intensive research and application of new technologies is paramount, driven by the increased aging population and lifestyle changes that heighten risk factors. End-use applications of CAD-related interventions span across hospitals, diagnostic centers, and specialty clinics, with an ever-growing emphasis on preventative and minimally invasive procedures. Key growth factors in the CAD market include advancements in diagnostic technologies such as artificial intelligence for predictive analytics, wearable health-monitoring devices, and the widespread implementation of telemedicine. The burgeoning focus on personalized medicine, mainly through genetic profiling and novel drug delivery systems, presents significant opportunities for stakeholders. To capitalize on these opportunities, companies should invest in R&D for innovative treatment approaches such as gene therapy, stem cell therapies, or the development of bioabsorbable stents, which can address unmet needs in CAD management. However, limitations such as high costs associated with advanced therapeutic technologies and regulatory challenges can impede market expansion. Additionally, the dependency on healthcare infrastructure in developing regions is a notable challenge. The highly competitive market nature necessitates differentiation through technological ingenuity and strategic alliances. Innovative research areas include the exploration of microRNA in gene silencing, enhancement of CRISPR for genome editing in CAD, and development in 3D-printed cardiovascular biomaterials. An insight into the market highlights the crucial role of emerging economies as untapped markets due to their increasing healthcare spending. Overall, continued innovation and strategic positioning, supported by comprehensive market analysis, will be key for businesses aiming to gain traction and expand their footprint in the dynamic CAD market.

KEY MARKET STATISTICS
Base Year [2023] USD 11.88 billion
Estimated Year [2024] USD 12.53 billion
Forecast Year [2030] USD 17.49 billion
CAGR (%) 5.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Artery Disease Market

The Coronary Artery Disease Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of coronary artery disease due to aging populations
    • Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
  • Market Restraints
    • High cost of advanced therapeutic devices and limited commercialization of advanced technologies
  • Market Opportunities
    • Advancements and improvements in CAD management products
    • Continuous expansion of minimally invasive procedures and surgery centers
  • Market Challenges
    • Problems associated with product recalls due to safety concerns

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Artery Disease Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Artery Disease Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Artery Disease Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Artery Disease Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Artery Disease Market

A detailed market share analysis in the Coronary Artery Disease Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Artery Disease Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Artery Disease Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Artery Disease Market

A strategic analysis of the Coronary Artery Disease Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences, FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., Genesee Biomedical Inc., Getinge AB, Hitachi, Ltd., Koninklijke Philips N.V., Medtronic PLC, Merck KGaA, MicroPort Scientific Corporation, Siemens Healthineer AG, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnostics and Treatment. The Diagnostics is further studied across Cardiac Catheterization & Angiogram, Echocardiogram, Electrocardiogram, Exercise Stress Test, Heart CT Scan, and Nuclear Stress Test. The Treatment is further studied across Medications and Surgeries. The Medications is further studied across Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin, Aspirin, Beta-blockers, Calcium Channel Blockers, Cholesterol Drugs, and Ranolazine. The Surgeries is further studied across Coronary Angioplasty & Stent Placement and Coronary Artery Bypass Graft Surgery.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Diagnostic Centers, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of coronary artery disease due to aging populations
      • 5.1.1.2. Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced therapeutic devices and limited commercialization of advanced technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CAD management products
      • 5.1.3.2. Continuous expansion of minimally invasive procedures and surgery centers
    • 5.1.4. Challenges
      • 5.1.4.1. Problems associated with product recalls due to safety concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing need for surgeries to manage CAD effectively and improve the quality of life
    • 5.2.2. End-User: Higher preferences for hospitals and clinics that offer integrated CAD care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Coronary Artery Disease Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostics
    • 6.2.1. Cardiac Catheterization & Angiogram
    • 6.2.2. Echocardiogram
    • 6.2.3. Electrocardiogram
    • 6.2.4. Exercise Stress Test
    • 6.2.5. Heart CT Scan
    • 6.2.6. Nuclear Stress Test
  • 6.3. Treatment
    • 6.3.1. Medications
      • 6.3.1.1. Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin
      • 6.3.1.2. Aspirin
      • 6.3.1.3. Beta-blockers
      • 6.3.1.4. Calcium Channel Blockers
      • 6.3.1.5. Cholesterol Drugs
      • 6.3.1.6. Ranolazine
    • 6.3.2. Surgeries
      • 6.3.2.1. Coronary Angioplasty & Stent Placement
      • 6.3.2.2. Coronary Artery Bypass Graft Surgery

7. Coronary Artery Disease Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Diagnostic Centers
  • 7.4. Hospitals & Clinics

8. Americas Coronary Artery Disease Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Coronary Artery Disease Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Coronary Artery Disease Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Abbott Introduces Enhanced Xience Sierra Stent System for Improved Cardiac Care
    • 11.3.2. Innovative Startup Revolutionizes Coronary Artery Disease Detection with AI Technology
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun SE
  • 3. Becton, Dickinson and Company
  • 4. Biotronik SE & Co. KG
  • 5. Boston Scientific Corporation
  • 6. Canon Medical Systems Corporation
  • 7. Edwards Lifesciences
  • 8. FUJIFILM Holdings Corporation
  • 9. GE HealthCare Technologies, Inc.
  • 10. Genesee Biomedical Inc.
  • 11. Getinge AB
  • 12. Hitachi, Ltd.
  • 13. Koninklijke Philips N.V.
  • 14. Medtronic PLC
  • 15. Merck KGaA
  • 16. MicroPort Scientific Corporation
  • 17. Siemens Healthineer AG
  • 18. Stryker Corporation
  • 19. Teleflex Incorporated
  • 20. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. CORONARY ARTERY DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. CORONARY ARTERY DISEASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CORONARY ARTERY DISEASE MARKET DYNAMICS
  • TABLE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIAC CATHETERIZATION & ANGIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EXERCISE STRESS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HEART CT SCAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY NUCLEAR STRESS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN II RECEPTOR BLOCKERS NITROGLYCERIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CHOLESTEROL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY RANOLAZINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ANGIOPLASTY & STENT PLACEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023